Piperine inhibits type II phosphatidylinositol 4-kinases: A key component in phosphoinositides turnover

Molecular and Cellular Biochemistry

Volumn 393, Issue 1-2, 2014, Pages 9-15

  Bojjireddy, Naveen ^a,b   Sinha, Ranjeet Kumar ^a   Subrahmanyam, Gosukonda ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Mast cell; Piperine; RBL 2H3 cells; Type II PtdIns 4 kinase; Hexosaminidase

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; FC EPSILON RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN E; LIPID; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL KINASE; PIPERINE; TYPE II PHOSPHATIDYLINOSITOL 4 KINASE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; IMMUNOGLOBULIN E RECEPTOR; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL PHOSPHATE 4-KINASE; PHOSPHOTRANSFERASE; PIPERIDINE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL LYSATE; CELL STIMULATION; CELL STRAIN RBL 2H3; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MAST CELL DEGRANULATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TURNOVER TIME; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MAST CELL; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ALKALOIDS; BENZODIOXOLES; CELL LINE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; MAST CELLS; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PIPERIDINES; POLYUNSATURATED ALKAMIDES; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 84903460190     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2041-3     Document Type: Article

References (39)

1. Naveen B, Shankar BS, Subrahmanyam G (2005) FcepsilonRI cross-linking activates a type II phosphatidylinositol 4-kinase in RBL-2H3 cells. Mol Immunol 42:1541-1549. doi:10.1016/j.molimm.2004.12.019 (Pubitemid 40798941)
2. Bojjireddy N, Sinha RK, Panda D, Subrahmanyam G (2013) Sanguinarine suppresses IgE induced inflammatory responses through inhibition of type II PtdIns 4-kinase(s). Arch Biochem Biophys 537:192-197. doi:10.1016/j.abb.2013.07. 017
3. Sinha RK, Subrahmanyam G (2007) Type II phosphatidylinositol 4-kinase(s) in cell signaling cascades. Indian J Biochem Biophys 44:289-294 (Pubitemid 351485581)
4. Fernandis AZ, Srivastava R, Sinha RK, Subrahmanyam G (2005) A type II phosphatidylinositol 4-kinase associates with T cell receptor zeta chain in Con A stimulated splenic lymphocytes through tyrosyl phosphorylation-dependent mechanisms. Mol Immunol 42:561-568. doi:10.1016/j.molimm.2004.09.016 (Pubitemid 39655933)
5. Guo J, Wenk MR, Pellegrini L, Onofri F, Benfenati F, De Camilli P (2003) Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci USA 100:3995-4000. doi:10.1073/pnas.0230488100 (Pubitemid 36418145)
6. Defacque H, Bos E, Garvalov B, Barret C, Roy C, Mangeat P, Shin HW, Rybin V, Griffiths G (2002) Phosphoinositides regulate membrane-dependent actin assembly by latex bead phagosomes. Mol Biol Cell 13:1190-1202. doi:10.1091/mbc.01-06-0314 (Pubitemid 34309615)
7. Bojjireddy N, Botyanszki J, Hammond G, Creech D, Peterson R, Kemp DC, Snead M, Brown R, Morrison A, Wilson S, Harrison S, Moore C, Balla T (2014) Pharmacological and genetic targeting of pPI4KA reveals its important role in maintaining plasma membrane PtdIns4p and PtdIns(4,5)P2 levels. J Biol Chem. doi:10.1074/jbc.M113.531426
8. Bojjireddy N, Sinha RK, Subrahmanyam G (2014) Type II phosphatidylinositol 4-kinases interact with FcepsilonRIgamma subunit in RBL-2H3 cells. Mol Cell Biochem. doi:10.1007/s11010-014-1970-1
9. Bojjireddy N, Sinha RK, Subrahmanyam G (2014) Fyn kinase regulates type II PtdIns 4-kinases in RBL-2H3 cells. Mol Cell Biochem 387:63-70. doi:10.1007/s11010-013-1871-8
10. Jovic M, Bojjireddy N, Kean M, Gingras A-C, Brill J, Balla T (2012) Regulation of PI4KII alpha distribution between the Golgi and endosomal compartments. FASEB J 26:2
11. Tai AW, Bojjireddy N, Balla T (2011) A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases. Anal Biochem 417:97-102. doi:10.1016/j.ab.2011.05.046
12. Szentpetery Z, Szakacs G, Bojjireddy N, Tai AW, Balla T (2011) Genetic and functional studies of phosphatidyl-inositol 4-kinase type IIIalpha. Biochim Biophys Acta 1811:476-483. doi:10.1016/j.bbalip.2011.04.013
13. Sinha RK, Bojjireddy N, Kulkarni D, Ratheesh A, Chiplunkar SV, Gude R, Subrahmanyam G (2013) Type II phosphatidylinositol 4-kinase beta is an integral signaling component of early T cell activation mechanisms. Biochimie. doi:10.1016/j.biochi.2013.04.005
14. Endemann G, Dunn SN, Cantley LC (1987) Bovine brain contains two types of phosphatidylinositol kinase. Biochemistry 26:6845-6852
15. Balla A, Tuymetova G, Barshishat M, Geiszt M, Balla T (2002) Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments. J Biol Chem 277:20041-20050. doi:10.1074/jbc.M111807200 (Pubitemid 34967528)
16. Barylko B, Gerber SH, Binns DD, Grichine N, Khvotchev M, Sudhof TC, Albanesi JP (2001) A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. J Biol Chem 276:7705-7708. doi:10.1074/jbc.C000861200
17. Desai DM, Newton ME, Kadlecek T, Weiss A (1990) Stimulation of the phosphatidylinositol pathway can induce T-cell activation. Nature 348:66-69. doi:10.1038/348066a0
18. Rudd CE, Janssen O, Cai YC, da Silva AJ, Raab M, Prasad KV (1994) Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: sH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 15:225-234
19. Weiss A, Iwashima M, Irving B, van Oers NS, Kadlecek TA, Straus D, Chan A (1994) Molecular and genetic insights into T cell antigen receptor signal transduction. Adv Exp Med Biol 365:53-62 (Pubitemid 24353275)
20. Costello PS, Gallagher M, Cantrell DA (2002) Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat Immunol 3:1082-1089. doi:10.1038/ni848 (Pubitemid 35363662)
21. Gehrmann T, Heilmeyer LM Jr (1998) Phosphatidylinositol 4-kinases. Eur J Biochem 253:357-370 (Pubitemid 28191836)
22. Heilmeyer LM Jr, Vereb G Jr, Vereb G, Kakuk A, Szivak I (2003) Mammalian phosphatidylinositol 4-kinases. IUBMB Life 55:59-65. doi:10.1002/tbmb.718540873 (Pubitemid 36534732)
23. Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SA, von dem Borne PA, van Rood JJ, Willemze R, Falkenburg JH (2008) Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci USA 105:3837-3842. doi:10.1073/pnas.0712250105 (Pubitemid 351723486)
24. Sinha RK, Patel RY, Bojjireddy N, Datta A, Subrahmanyam G (2011) Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover. Arch Biochem Biophys 516:45-51. doi:10.1016/j.abb.2011.09.005
25. Srivastava R, Sinha RK, Subrahmanyam G (2006) Type II phosphatidylinositol 4-kinase beta associates with TCR-CD3 zeta chain in Jurkat cells. Mol Immunol 43:454-463. doi:10.1016/j.molimm.2005.03.009 (Pubitemid 41740434)
26. Yue J, Liu J, Shen X (2001) Inhibition of phosphatidylinositol 4-kinase results in a significant reduced respiratory burst in formyl-methionyl-leucyl- phenylalanine-stimulated human neutrophils. J Biol Chem 276:49093-49099. doi:10.1074/jbc.M101328200
27. Dudhatra GB, Mody SK, Awale MM, Patel HB, Modi CM, Kumar A, Kamani DR, Chauhan BN (2012) A comprehensive review on pharmacotherapeutics of herbal bioenhancers. ScientificWorldJournal 2012:637953. doi:10.1100/2012/637953
28. Khajuria A, Zutshi U, Bedi KL (1998) Permeability characteristics of piperine on oral absorption-an active alkaloid from peppers and a bioavailability enhancer. Indian J Exp Biol 36:46-50 (Pubitemid 28063097)
29. Bae GS, Kim MS, Jung WS, Seo SW, Yun SW, Kim SG, Park RK, Kim EC, Song HJ, Park SJ (2010) Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol 642:154-162. doi:10.1016/j.ejphar.2010. 05.026
30. Srinivasan K (2007) Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 47:735-748. doi:10.1080/10408390601062054
31. Gupta SK, Bansal P, Bhardwaj RK, Velpandian T (2000) Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res 41:657-662. doi:10.1006/phrs.1999.0640
32. Fernandis AZ, Subrahmanyam G (1998) Concanavalin A modulates tyrosine phosphorylation and activation of a type II phosphatidylinositol 4-kinase in rat splenic lymphocytes. Mol Immunol 35:935-941 (Pubitemid 28563360)
33. Singh DV, Godbole MM, Misra K (2013) A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. J Mol Model 19:227-238. doi:10.1007/s00894-012- 1535-8
34. Iwashita M, Saito M, Yamaguchi Y, Takagaki R, Nakahata N (2007) Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor. Biol Pharm Bull 30:1221-1225 (Pubitemid 47037642)
35. Uwabe K, Iwakawa T, Matsumoto M, Talkahashi K, Nagata K (2006) HU0622: a small molecule promoting GAP-43 activation and neurotrophic effects. Neuropharmacology 51:727-736. doi:10.1016/j.neuropharm.2006.05.014 (Pubitemid 44286929)
36. Ishihara Y, Furuno T, Nakanishi M (2006) The role of phosphatidylinositol 4-kinase type IIalpha in degranulation of RBL-2H3 cells. Inflamm Res 55:465-468. doi:10.1007/s00011-006-6062-6 (Pubitemid 44826735)
37. Clayton EL, Minogue S, Waugh MG (2013) Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. Prog Lipid Res 52:294-304. doi:10.1016/j.plipres.2013.04.002
38. Meghwal M, Goswami TK (2013) Piper nigrum and piperine: an update. Phytother Res 27:1121-1130. doi:10.1002/ptr.4972
39. Edwards E, Ashby CR Jr, Wang RY (1992) (±)-1-(2,5-Dimethoxy-4- iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex. Neuropharmacology 31:615-621